After testing the method, called ARTEMIS-DELFI, in blood samples from patients participating in two large clinical trials of pancreatic cancer treatments, researchers found that it could be used to identify therapeutic responses. ARTEMIS-DELFI and another method developed by investigators, called…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.